2634 篇
1089 篇
194703 篇
3325 篇
6317 篇
2231 篇
2785 篇
537 篇
29654 篇
9790 篇
3163 篇
759 篇
2303 篇
1321 篇
449 篇
752 篇
1387 篇
2611 篇
2740 篇
4029 篇
全球视网膜药物市场报告(2025-2029年)
Global Retinal Drugs Market 2025-2029
Retinal drugs are the medications that are used in the treatment of retinal diseases. Anti-vascular endothelial growth factor (VEGF) agents and corticosteroids are the two major drug classes that are being used for the treatment of various retinal diseases such as wet age-related Macular degeneration (AMD), macular edema following retinal vein occlusion (RVO), diabetic macular edema (DME), diabetic retinopathy, and myopic choroidal neovascularization (mCNV). Among them, anti-VEGF agents are considered the gold standard for the treatment of various retinal diseases such as AMD, DME, and RVO.